JP2006188525A5 - - Google Patents

Download PDF

Info

Publication number
JP2006188525A5
JP2006188525A5 JP2006016490A JP2006016490A JP2006188525A5 JP 2006188525 A5 JP2006188525 A5 JP 2006188525A5 JP 2006016490 A JP2006016490 A JP 2006016490A JP 2006016490 A JP2006016490 A JP 2006016490A JP 2006188525 A5 JP2006188525 A5 JP 2006188525A5
Authority
JP
Japan
Prior art keywords
trimethoxyphenyl
methyl
sulfonamide
trimethoxy
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006016490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006188525A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006188525A publication Critical patent/JP2006188525A/ja
Publication of JP2006188525A5 publication Critical patent/JP2006188525A5/ja
Pending legal-status Critical Current

Links

JP2006016490A 1999-05-28 2006-01-25 細胞増殖抑制剤 Pending JP2006188525A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32233999A 1999-05-28 1999-05-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005174115A Division JP3869847B2 (ja) 1999-05-28 2005-06-14 細胞増殖抑制剤

Publications (2)

Publication Number Publication Date
JP2006188525A JP2006188525A (ja) 2006-07-20
JP2006188525A5 true JP2006188525A5 (https=) 2007-05-31

Family

ID=23254447

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000621331A Expired - Fee Related JP3702183B2 (ja) 1999-05-28 2000-05-26 細胞増殖抑制剤
JP2005174115A Expired - Fee Related JP3869847B2 (ja) 1999-05-28 2005-06-14 細胞増殖抑制剤
JP2006016490A Pending JP2006188525A (ja) 1999-05-28 2006-01-25 細胞増殖抑制剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2000621331A Expired - Fee Related JP3702183B2 (ja) 1999-05-28 2000-05-26 細胞増殖抑制剤
JP2005174115A Expired - Fee Related JP3869847B2 (ja) 1999-05-28 2005-06-14 細胞増殖抑制剤

Country Status (16)

Country Link
EP (1) EP1181269B1 (https=)
JP (3) JP3702183B2 (https=)
AR (1) AR024138A1 (https=)
AT (1) ATE260248T1 (https=)
AU (1) AU5170900A (https=)
BR (1) BR0007589A (https=)
CA (1) CA2371092A1 (https=)
CO (1) CO5170498A1 (https=)
DE (1) DE60008527T2 (https=)
DK (1) DK1181269T3 (https=)
ES (1) ES2215668T3 (https=)
HK (1) HK1045299B (https=)
MX (1) MXPA01012226A (https=)
PT (1) PT1181269E (https=)
TW (1) TWI221837B (https=)
WO (1) WO2000073264A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775305B2 (en) * 1999-07-29 2004-07-29 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamide and platin compound
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
WO2002039958A2 (en) 2000-11-03 2002-05-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
EP1343782B1 (en) * 2000-12-21 2009-05-06 SmithKline Beecham Corporation Pyrimidineamines as angiogenesis modulators
JP2005516927A (ja) * 2001-12-13 2005-06-09 アボット・ラボラトリーズ 癌治療用のキナーゼ阻害剤としての3−(フェニル−アルコキシ)−5−(フェニル)−ピリジン誘導体および関連化合物
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
FR2836914B1 (fr) * 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
CA2612554A1 (en) * 2005-06-28 2007-01-04 Merck & Co., Inc. Non-nucleoside reverse transcriptase inhibitors
US8017781B2 (en) * 2005-11-15 2011-09-13 Vertex Pharmaceuticals Incorporated Azaindazoles useful as inhibitors of kinases
WO2008061247A2 (en) * 2006-11-16 2008-05-22 The Regent Of The University Of California Benzenesulfonanilide compound inhibitors of urea transporters
WO2008114831A1 (ja) * 2007-03-20 2008-09-25 National University Corporation Okayama University スルホンアミド基を有する抗菌剤
DK2219451T3 (en) 2007-11-21 2015-01-12 Oxigene Inc A method for the treatment of hematopoietic neoplasms
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
US9034875B2 (en) 2009-05-26 2015-05-19 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US20220315555A1 (en) 2009-05-26 2022-10-06 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US8546399B2 (en) 2009-05-26 2013-10-01 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
WO2014089177A2 (en) 2012-12-04 2014-06-12 Massachusetts Institute Of Technology Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
US10201623B2 (en) 2013-03-15 2019-02-12 Memorial Sloan Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
FR3030516B1 (fr) * 2014-12-19 2019-12-27 Galderma Research & Development Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)
EP3337495A4 (en) 2015-08-18 2019-04-10 Mateon Therapeutics, Inc. USE OF VDA TO ENHANCE IMMUNOMODULATION THERAPIES AGAINST TUMORS
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013621A (en) * 1975-04-29 1977-03-22 Ciba-Geigy Corporation Substituted sulfonamide derivatives of hindered phenols and stabilized compositions
IT1050750B (it) * 1975-12-05 1981-03-20 Erba Carlo Spa Derivati della 3.4 di idro chinazolina
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
GB8804457D0 (en) * 1988-02-25 1988-03-23 Ciba Geigy Ag Compositions
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
JPH04202173A (ja) * 1990-11-30 1992-07-22 Zeria Pharmaceut Co Ltd スルホンアミド誘導体及びそれを含有する5―リポキシゲナーゼ阻害剤
GB9200415D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Inactivation of cytotoxic drugs
JPH06206805A (ja) * 1992-02-17 1994-07-26 Hisamitsu Pharmaceut Co Inc チロシナーゼ阻害剤及びそれを用いた皮膚外用剤
JPH06199047A (ja) * 1993-01-08 1994-07-19 New Oji Paper Co Ltd 感熱記録体
JPH08176113A (ja) * 1993-11-12 1996-07-09 Dainippon Pharmaceut Co Ltd 2−スルフィニルニコチンアミド誘導体及びその中間体並びにそれを有効成分とする消化性潰瘍治療薬
JPH09179257A (ja) * 1995-12-22 1997-07-11 Konica Corp ハロゲン化銀カラー写真感光材料
PT939627E (pt) * 1996-07-19 2004-02-27 Tularik Inc Pentafluorobenzenossulfonamidas e analogos
BR9714087A (pt) * 1996-12-27 2000-05-09 Daiichi Seiyaku Co Derivados de propionil substituìdo.
JPH10316650A (ja) * 1997-05-13 1998-12-02 Dev Center For Biotechnol 新規な抗アテローム性動脈硬化薬
IL164568A0 (en) * 1997-05-14 2005-12-18 Atherogenics Inc Compounds and methods for the inhibition of the expression of vcam-1
US6191170B1 (en) * 1998-01-13 2001-02-20 Tularik Inc. Benzenesulfonamides and benzamides as therapeutic agents
ATE248845T1 (de) * 1998-06-25 2003-09-15 Tularik Inc Arylsulfonanilid-phosphate
CN1332849A (zh) * 1998-11-09 2002-01-23 埃瑟若詹尼克斯公司 降低血浆胆固醇水平的方法和组合物

Similar Documents

Publication Publication Date Title
JP2006188525A5 (https=)
RU2337098C2 (ru) Новые производные бензимидазола и фармацевтическая композиция на их основе для использования в лечении расстройств, опосредованных vr1
FI108792B (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten furanonijohdannaisten valmistamiseksi
JP3869847B2 (ja) 細胞増殖抑制剤
JP2005522438A5 (https=)
ES2353077T3 (es) Derivados de urea con sustitución en posición 3 y uso medicinal de los mismos.
RU2502730C2 (ru) Сульфонамидные соединения и их применение
ES2675074T3 (es) Compuestos de aril-fenil-sulfonamida-fenileno y su uso
RU2011134634A (ru) Индуцирующие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний
KR101063462B1 (ko) 아릴 및 헤테로아릴 프로펜 아미드, 이들의 유도체 및 이의치료학적 용도
JP2009537595A5 (https=)
KR940014337A (ko) 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제
JP2005523920A5 (https=)
JPWO2020094104A5 (https=)
JP2010526025A5 (https=)
CY1109409T1 (el) Κρυσταλλοι παραγωγου υδροξυνορεφεδρινης
US20100317739A1 (en) Histone deacetylase inhibitors
JP2005530852A5 (https=)
RU2008149936A (ru) (2r)-2-[(4-сульфонил)аминофенил]пропанамиды и содержащие их фармацевтические композиции
JP2004524345A5 (https=)
JP2002501043A5 (https=)
CA2659746A1 (en) Aryl vinyl sulfides, sulfones, sulfoxides and sulfonamides, derivatives thereof and therapeutic uses thereof
JP4538233B2 (ja) 増殖性障害治療用の、アミノ置換されたスルホンアニリド及びその誘導体
RU2002123337A (ru) Аминосульфонилбифенильные производные
JP2007516211A5 (https=)